NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zencore Biologics

Zencore Biologics

Private
ShanghaiHealthcare & Life Scienceshttps://zgbiotech.com/

Last Round

Series C

Extension

Aug 19, 2022

Total Funding Raised

$335.74M

Company Overview

Zencore Biologics is a biotechnology company providing comprehensive contract development and manufacturing (CDMO) services that support pharmaceutical enterprises in the development and production of macromolecular drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMObiologics manufacturingcell line developmentcGMP manufacturingbiopharma outsourcingprocess developmentfill and finishanalytical developmentmonoclonal antibodiesclinical supplybiotech servicesdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zencore Biologics Comparables

Compare Zencore Biologics with similar companies based on industry and business-model similarity.

Zencore Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
甲贝医药科技有限公司
94%
Chime Biologics
93%
Intellective Biologics (Suzhou) Co., Ltd.
91%

Zencore Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionAug 19, 2022
Series CJan 25, 2022
Series COct 27, 2021
Series BMar 22, 2021
Series AMar 31, 2020

Key People

Founding team and executive leadership

Min Zhu

CTO

Executive Team

Zencore Biologics Investors

Notable investors and investment history

Zencore Biologics investors
InvestorRounds
IDG CapitalSeries C, Series A, Series B
Korea Investment PartnersSeries A
招银国际金融有限公司Series B
Guoke Jiahe CapitalSeries B
China International Capital CorporationSeries C Extension
Lingang Blue Bay CapitalSeries C Extension
LYFE CapitalSeries C, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 66% MoM, reaching 2.9K.

  • Jan 21, 2026

    Monthly visitors increased 49% MoM.

Zencore Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zencore Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zencore Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range44
Year Founded2017
Last FundingAug 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.